196 related articles for article (PubMed ID: 38477310)
1. Elucidating the Mechanism of Metabolism of Cannabichromene by Human Cytochrome P450s.
Roy P; Maturano J; Hasdemir H; Lopez A; Xu F; Hellman J; Tajkhorshid E; Sarlah D; Das A
J Nat Prod; 2024 Apr; 87(4):639-651. PubMed ID: 38477310
[TBL] [Abstract][Full Text] [Related]
2. Metabolites of Cannabigerol Generated by Human Cytochrome P450s Are Bioactive.
Roy P; Dennis DG; Eschbach MD; Anand SD; Xu F; Maturano J; Hellman J; Sarlah D; Das A
Biochemistry; 2022 Nov; 61(21):2398-2408. PubMed ID: 36223199
[TBL] [Abstract][Full Text] [Related]
3. Hydroxychloroquine is Metabolized by Cytochrome P450 2D6, 3A4, and 2C8, and Inhibits Cytochrome P450 2D6, while its Metabolites also Inhibit Cytochrome P450 3A
Paludetto MN; Kurkela M; Kahma H; Backman JT; Niemi M; Filppula AM
Drug Metab Dispos; 2023 Mar; 51(3):293-305. PubMed ID: 36446607
[TBL] [Abstract][Full Text] [Related]
4. Understanding a substrate's product regioselectivity in a family of enzymes: a case study of acetaminophen binding in cytochrome P450s.
Yang Y; Wong SE; Lightstone FC
PLoS One; 2014; 9(2):e87058. PubMed ID: 24498291
[TBL] [Abstract][Full Text] [Related]
5. Ferrous and ferric state of cytochromes P450 in intact Escherichia coli cells: a possible role of cytochrome P450-flavodoxin interactions.
Culka M; Milichovsky J; Jerabek P; Stiborova M; Martinek V
Neuro Endocrinol Lett; 2015; 36 Suppl 1():29-37. PubMed ID: 26757119
[TBL] [Abstract][Full Text] [Related]
6. Cross-talk of cannabinoid and endocannabinoid metabolism is mediated via human cardiac CYP2J2.
Arnold WR; Weigle AT; Das A
J Inorg Biochem; 2018 Jul; 184():88-99. PubMed ID: 29689453
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450-Catalyzed Metabolism of Cannabidiol to the Active Metabolite 7-Hydroxy-Cannabidiol.
Beers JL; Fu D; Jackson KD
Drug Metab Dispos; 2021 Oct; 49(10):882-891. PubMed ID: 34330718
[TBL] [Abstract][Full Text] [Related]
8. CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide.
Bidstrup TB; Bjørnsdottir I; Sidelmann UG; Thomsen MS; Hansen KT
Br J Clin Pharmacol; 2003 Sep; 56(3):305-14. PubMed ID: 12919179
[TBL] [Abstract][Full Text] [Related]
9. Stable Chinese Hamster Ovary Suspension Cell Lines Harboring Recombinant Human Cytochrome P450 Oxidoreductase and Human Cytochrome P450 Monooxygenases as Platform for In Vitro Biotransformation Studies.
Schulz C; Herzog N; Kubick S; Jung F; Küpper JH
Cells; 2023 Aug; 12(17):. PubMed ID: 37681872
[TBL] [Abstract][Full Text] [Related]
10. Flexibility of human cytochrome P450 enzymes: molecular dynamics and spectroscopy reveal important function-related variations.
Hendrychová T; Anzenbacherová E; Hudeček J; Skopalík J; Lange R; Hildebrandt P; Otyepka M; Anzenbacher P
Biochim Biophys Acta; 2011 Jan; 1814(1):58-68. PubMed ID: 20656072
[TBL] [Abstract][Full Text] [Related]
11. Metabolic characterization of (1-(5-fluoropentyl)-1H-indol-3-yl)(4-methyl-1-naphthalenyl)-methanone (MAM-2201) using human liver microsomes and cDNA-overexpressed cytochrome P450 enzymes.
Kong TY; Kim JH; Choi WG; Lee JY; Kim HS; Kim JY; In MK; Lee HS
Anal Bioanal Chem; 2017 Feb; 409(6):1667-1680. PubMed ID: 27924364
[TBL] [Abstract][Full Text] [Related]
12. Human recombinant cytochrome P450 enzymes display distinct hydrogen peroxide generating activities during substrate independent NADPH oxidase reactions.
Mishin V; Heck DE; Laskin DL; Laskin JD
Toxicol Sci; 2014 Oct; 141(2):344-52. PubMed ID: 25061110
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone.
Baldwin SJ; Clarke SE; Chenery RJ
Br J Clin Pharmacol; 1999 Sep; 48(3):424-32. PubMed ID: 10510156
[TBL] [Abstract][Full Text] [Related]
14. Confirmation that cytochrome P450 2C8 (CYP2C8) plays a minor role in (S)-(+)- and (R)-(-)-ibuprofen hydroxylation in vitro.
Chang SY; Li W; Traeger SC; Wang B; Cui D; Zhang H; Wen B; Rodrigues AD
Drug Metab Dispos; 2008 Dec; 36(12):2513-22. PubMed ID: 18787056
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands.
Chimalakonda KC; Seely KA; Bratton SM; Brents LK; Moran CL; Endres GW; James LP; Hollenberg PF; Prather PL; Radominska-Pandya A; Moran JH
Drug Metab Dispos; 2012 Nov; 40(11):2174-84. PubMed ID: 22904561
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoids and Cytochrome P450 Interactions.
Zendulka O; Dovrtělová G; Nosková K; Turjap M; Šulcová A; Hanuš L; Juřica J
Curr Drug Metab; 2016; 17(3):206-26. PubMed ID: 26651971
[TBL] [Abstract][Full Text] [Related]
17. In vitro metabolism of a novel synthetic cannabinoid, EAM-2201, in human liver microsomes and human recombinant cytochrome P450s.
Kim JH; Kim HS; Kong TY; Lee JY; Kim JY; In MK; Lee HS
J Pharm Biomed Anal; 2016 Feb; 119():50-8. PubMed ID: 26641707
[TBL] [Abstract][Full Text] [Related]
18. Protein-Ligand Identification and
Lim SYM; Loo JSE; Alshagga M; Alshawsh MA; Ong CE; Pan Y
Int J Toxicol; 2022; 41(5):355-366. PubMed ID: 35658727
[TBL] [Abstract][Full Text] [Related]
19. Significant change of cytochrome P450s activities in patients with hepatocellular carcinoma.
Zhou J; Wen Q; Li SF; Zhang YF; Gao N; Tian X; Fang Y; Gao J; Cui MZ; He XP; Jia LJ; Jin H; Qiao HL
Oncotarget; 2016 Aug; 7(31):50612-50623. PubMed ID: 27203676
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cytochrome P450 enzymes involved in ketamine metabolism by use of liver microsomes and specific cytochrome P450 enzymes from horses, dogs, and humans.
Mössner LD; Schmitz A; Theurillat R; Thormann W; Mevissen M
Am J Vet Res; 2011 Nov; 72(11):1505-13. PubMed ID: 22023129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
